The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
Official Title: A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride in Extending the Time to Progression of Low-Risk, Localized Prostate Cancer in Men Who Are Candidates for or Undergoing Expectant Management
Study ID: NCT00363311
Brief Summary: The purpose of this study is to examine the effect of dutasteride on the inhibition of low-risk, localized prostate cancer progression in men who would otherwise receive no active therapy (expectant management).
Detailed Description:
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
GSK Investigational Site, Little Rock, Arkansas, United States
GSK Investigational Site, Beverly Hills, California, United States
GSK Investigational Site, Laguna Hills, California, United States
GSK Investigational Site, Mission Hills, California, United States
GSK Investigational Site, Modesto, California, United States
GSK Investigational Site, San Bernardino, California, United States
GSK Investigational Site, Torrance, California, United States
GSK Investigational Site, Englewood, Colorado, United States
GSK Investigational Site, Wheat Ridge, Colorado, United States
GSK Investigational Site, New Britain, Connecticut, United States
GSK Investigational Site, Trumbull, Connecticut, United States
GSK Investigational Site, Washington, District of Columbia, United States
GSK Investigational Site, Jacksonville, Florida, United States
GSK Investigational Site, Largo, Florida, United States
GSK Investigational Site, Orlando, Florida, United States
GSK Investigational Site, Roswell, Georgia, United States
GSK Investigational Site, Coeur D'Alene, Idaho, United States
GSK Investigational Site, Chicago, Illinois, United States
GSK Investigational Site, Melrose Park, Illinois, United States
GSK Investigational Site, Fort Wayne, Indiana, United States
GSK Investigational Site, Newburgh, Indiana, United States
GSK Investigational Site, Overland Park, Kansas, United States
GSK Investigational Site, Shreveport, Louisiana, United States
GSK Investigational Site, Annapolis, Maryland, United States
GSK Investigational Site, Greenbelt, Maryland, United States
GSK Investigational Site, Watertown, Massachusetts, United States
GSK Investigational Site, Minneapolis, Minnesota, United States
GSK Investigational Site, St. Cloud, Minnesota, United States
GSK Investigational Site, Jackson, Mississippi, United States
GSK Investigational Site, St. Louis, Missouri, United States
GSK Investigational Site, Las Vegas, Nevada, United States
GSK Investigational Site, Marlton, New Jersey, United States
GSK Investigational Site, Albuquerque, New Mexico, United States
GSK Investigational Site, Albany, New York, United States
GSK Investigational Site, Elmont, New York, United States
GSK Investigational Site, Garden City, New York, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, Orchard Park, New York, United States
GSK Investigational Site, Syracuse, New York, United States
GSK Investigational Site, Greensboro, North Carolina, United States
GSK Investigational Site, Salisbury, North Carolina, United States
GSK Investigational Site, Winston-Salem, North Carolina, United States
GSK Investigational Site, Columbus, Ohio, United States
GSK Investigational Site, Springfield, Oregon, United States
GSK Investigational Site, Bala Cynwyd, Pennsylvania, United States
GSK Investigational Site, Lancaster, Pennsylvania, United States
GSK Investigational Site, Philadelphia, Pennsylvania, United States
GSK Investigational Site, Memphis, Tennessee, United States
GSK Investigational Site, Nashville, Tennessee, United States
GSK Investigational Site, San Antonio, Texas, United States
GSK Investigational Site, Temple, Texas, United States
GSK Investigational Site, Salt Lake City, Utah, United States
GSK Investigational Site, Richmond, Virginia, United States
GSK Investigational Site, Virginia Beach, Virginia, United States
GSK Investigational Site, Williamsburg, Virginia, United States
GSK Investigational Site, Seattle, Washington, United States
GSK Investigational Site, Seattle, Washington, United States
GSK Investigational Site, Spokane, Washington, United States
GSK Investigational Site, Surrey, British Columbia, Canada
GSK Investigational Site, Victoria, British Columbia, Canada
GSK Investigational Site, Victoria, British Columbia, Canada
GSK Investigational Site, Fredericton, New Brunswick, Canada
GSK Investigational Site, Barrie, Ontario, Canada
GSK Investigational Site, Brampton, Ontario, Canada
GSK Investigational Site, Brantford, Ontario, Canada
GSK Investigational Site, Burlington, Ontario, Canada
GSK Investigational Site, Burlington, Ontario, Canada
GSK Investigational Site, Guelph, Ontario, Canada
GSK Investigational Site, Kitchener, Ontario, Canada
GSK Investigational Site, North Bay, Ontario, Canada
GSK Investigational Site, Oakville, Ontario, Canada
GSK Investigational Site, Scarborough, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Chicoutimi, Quebec, Canada
GSK Investigational Site, Greenfield Park, Quebec, Canada
GSK Investigational Site, Laval, Quebec, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Pointe-Claire, Quebec, Canada
GSK Investigational Site, Quebec City, Quebec, Canada
GSK Investigational Site, Trois Rivieres, Quebec, Canada
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR